View drug registration information details.
Items | Registration information |
ID | 432 |
No | 432 |
Brand Name | AVASTIN 100 MG/4 ML |
Ingredients | BEVACIZUMAB 100 MG/4ML |
Dosage Form | SOLUTION FOR INFUSION |
Primary Packaging | VIAL |
Storage | STORE AT 2-8.C. KEEP VIAL IN OUTER CARTON, DO NOT FREEZE |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 1 VIAL X 4 ML |
Dispensing Category | Prescription only |
ATC Classification | L01XC07 |
Pharmaceutical Class | ANTINEOPLASTIC |
Indications | METASTATIC COLORECTAL CANCER; LOCALLY RECURRENT OR METASTATIC BREAST CANCER; ADVANCED, METASTATIC OR RECURRENT NON SMALL CELL LUNG CANCER; ADVANCED AND/OR METASTATIC RENAL CELL CANCER… |
Contraindications | HYPERSENSITIVITY TO ANY OF COMPONENTS OF THE PRODUCT, CHINESE HAMSTER OVARY CELL PRODUCTS OR OTHER RECOMBINANT HUMAN OR HUMANNIZED ANTIBODIES |
Side Effects | ANOREXIA, DYSGUESIA, HEADACHE, EYE SISORDER, DISPNEA, CONSTIPATION |
Unit Price | 317.7$/1VI |
EDL |
Yes |
Description | COLORLESS, OPALESCENT LIQUID, PRACTICALLY FREE FROM PARTICLES |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | F.HOFFMANN LA ROCHE LTD. |
Country | SWITZERLAND |
Import Registration No | 56'922 01 |
Import Registration Date | 2014-12-09 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-10-07 |
FDD Registration No | 06 I 3125/08 |
FDD Registration Date | 2022-07-22 |
Expiry Date | 2025-07-21 |
Back to drug list
|